Cancer vaccines: Challenges and potential solutions

Molecular Medicine Today

Volumn 3, Issue 7, 1997, Pages 286-290

  Hellström, Karl Erik ^a   Gladstone, Paul ^a   Hellström, Ingegerd ^a,b  

^a BRISTOL MYERS SQUIBB   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

CANCER; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CANCER RESEARCH; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW;

EID: 0031405968     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01048-4     Document Type: Article

References (26)

1. Hellström, K. and Hellström, I. (1969) Cellular immunity against tumor specific antigens, Adv. Cancer Res. 12, 167-223
2. Boon, T. (1992) Toward a genetic analysis of tumor rejection antigens, Ann. Inst. Pasteur Immunol. 58, 177-210
3. Hellström, K.E., Hellström, I. and Chen, L. (1995) Can co-stimulated tumor immunity be therapeutically efficacious? Immunol. Rev. 145, 123-145
4. Pardoll, D.M. (1994) Tumor antigens: a new look for the 1990s, Nature 369, 357-358
5. Boon, T. and van der Bruggen, P. (1996) Human tumor antigens recognized by T lymphocytes, J. Exp. Med. 183, 1173-1183
6. Hellström, K.E. and Hellström, I. (1989) Oncogene-associated tumor antigens as targets for immunotherapy, FASEB J. 3, 1715-1720
7. Mellins, E. et al. (1991) A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex, J. Exp. Med. 174, 1607-1615
8. Neisig, J. et al. (1996) Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing, J. Immunol. 156, 3196-3206
9. Finn, O.J. et al. (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines, Immunol. Rev. 145, 61-89
10. Linsley, P.S. and Ledbetter, J.A. (1993) The role of the CD28 receptor during T cell responses to antigen, Annu. Rev. Immunol. 11, 191-212
11. June, C.H. et al. (1994) The B7 and CD28 receptor families, Immunol. Today 15, 321-331
12. Marincola, F.M. et al. (1994) Loss of HLA haplo-type and B locus down-regulation in melanoma cell lines, J. Immunol. 153, 1225-1237
13. Garrido, F. et al. (1993) Natural history of HLA expression during tumor development, Immunol Today 14, 491-499
14. Stern, P.L. and Duggan-Keen, M. (1994) MHC expression in the natural history of cervical cancer, in Human Papillomaviruses and Cervical Cancer: Biology and Immunology (Stern, P. and Stanley, M., eds), pp. 162-176, Oxford University Press
15. Wei, M.L. and Cresswell, P. (1992) HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides, Nature 356, 443-446
16. Restifo, N.P. et al. (1993) Identification of human cancers deficient in antigen processing, J. Exp. Med. 177, 265-272
17. Lehmann, F. et al. (1995) Differences in the antigens recognized by cytolytic T cells on successive metastases of a melanoma patient are consistent with immune selection, Eur. J. Immunol. 25, 340-347
18. Elliott, T. (1996) Tapping into tumours, Nat. Genet. 13, 139-140
19. Klein, E., Klein, G. and Hellström, K.E. (1960) Further studies on isoantigenic variation in mouse carcinomas and sarcomas, J. Natl. Cancer Inst. 25, 271-274
20. Sjögren, H.O. (1965) Transplantation methods as a tool for detection of tumor specific antigens, Prog. Exp. Tumor Res. 6, 289-296
21. Berke, Z. et al. (1996) A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity, J. Virol. 70, 3093-3097
22. Porgador, A. et al. (1995) Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases, Cancer Res. 55, 4941-4949
23. + T cells against the wild-type tumor: correlation with antigen presentation capability, J. Exp. Med. 175, 1423-1431
24. Van den Driessche, T. et al. (1994) Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens, Int. J. Cancer 58, 217-225
25. Kärre, K. (1995) Express yourself or die: peptides, MHC molecules, and NK cells, Science 267, 978-979
26. Greenberg, P.D. (1991) Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells, Adv. Immunol. 49, 281-355